Journey Medical (DERM) Price to Book (2021 - 2026)

Journey Medical (DERM) has reported Price to Book for 6 consecutive years, with 6.06 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Price to Book fell 30.24% year-over-year to 6.06; the trailing twelve-month figure through Jun 2026 stood at 6.06 (down 30.24% YoY), and the FY2025 full-year result was 5.12, up 28.58% from the prior year.
• Price to Book improved to 6.06 in Q2 2026 per DERM's latest filing, from 4.15 in the prior quarter.
• Across five years, Price to Book topped out at 5725.61 in Q2 2023 and bottomed at 1.66 in Q3 2022.
• Historically, Price to Book has averaged 322.83 across 5 years, with a median of 5.14 in 2023.
• The sharpest annual moves came in 2023 and 2024: Price to Book jumped 305057.97% in 2023, then slumped 99.83% in 2024.
• Over 5 years, Price to Book stood at 1.98 in 2022, then soared by 160.36% to 5.16 in 2023, then fell by 22.87% to 3.98 in 2024, then climbed by 28.58% to 5.12 in 2025, then increased by 18.43% to 6.06 in 2026.
• According to Business Quant data, Price to Book over the past three periods registered 6.06, 4.15, and 5.12 for Q2 2026, Q1 2026, and Q4 2025 respectively.